mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.008 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.008 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
0.37 |
0.02 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |